Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells
- PMID: 3000583
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells
Abstract
Epidermal growth factor (EGF) receptors are present in human breast cancer and probably mediate the effects of EGF and the autocrine effects of alpha-transforming growth factors, produced by breast cancer cells. Steroid hormones influence the growth of some human cancers, and both direct and indirect effects on cell proliferation have been proposed. One potential indirect effect of steroids would be to augment sensitivity to other endocrine and autocrine factors by up-regulation of their receptors. We therefore investigated the effects of various steroids on EGF receptor expression in T-47D, MCF-7, and BT 20 human mammary carcinoma cells in culture. Preincubation of T-47D cells for 24 h with a series of androgens, estrogens, glucocorticoids, and progestins resulted in a significant enhancement of specific 125I-EGF binding in the presence of progestins only. Increased binding of EGF was associated with neither a change in cell number nor changes in the specific binding of concanavalin A, insulin, or calcitonin but was accompanied by an increase in lactogenic receptor expression. When assayed at 20 degrees C, increased EGF binding was due to an increase in receptor number (33,380 +/- 7,410 sites/cell in control cultures; 67,460 +/- 20,330 sites/cell in cultures treated with 1 nM medroxyprogesterone acetate for 24 h; P less than 0.05) without a change in receptor affinity. Two- to 3-fold increases in receptor number were also apparent when binding was measured at 4 degrees C, indicating that the effect was due to an increase in expression of receptor at the cell surface rather than progestin effects on internalization and degradation. These data illustrate that the expression of EGF receptor in some breast cancer cells is regulated in part by mechanisms mediated via the progesterone receptor, since the effect was confined to progestins, potency among a series of progestins was correlated with their affinities for progesterone receptor, and sensitivity among the three cell lines studied was related to the presence and concentration of cellular progesterone receptor.
Similar articles
-
Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.Cancer Res. 1988 May 15;48(10):2734-9. Cancer Res. 1988. PMID: 2834048
-
Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.Cancer Res. 1991 Apr 15;51(8):2051-7. Cancer Res. 1991. PMID: 1849041
-
Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.Cancer Res. 1989 Jan 1;49(1):112-6. Cancer Res. 1989. PMID: 2642286
-
Epidermal growth factor: receptor and ligand expression in human breast cancer.Semin Cancer Biol. 1990 Oct;1(5):305-15. Semin Cancer Biol. 1990. PMID: 2103505 Review.
-
Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.Crit Rev Oncog. 1991;2(2):173-85. Crit Rev Oncog. 1991. PMID: 1677274 Review.
Cited by
-
The effect of age and menstrual cycle upon proliferative activity of the normal human breast.Br J Cancer. 1988 Aug;58(2):163-70. doi: 10.1038/bjc.1988.185. Br J Cancer. 1988. PMID: 3166907 Free PMC article.
-
Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells.Breast Cancer Res. 2004;6(3):R239-45. doi: 10.1186/bcr780. Epub 2004 Mar 18. Breast Cancer Res. 2004. PMID: 15084247 Free PMC article.
-
The glucocorticoid receptor signalling in breast cancer.J Cell Mol Med. 2008 Jan-Feb;12(1):145-63. doi: 10.1111/j.1582-4934.2007.00177.x. Epub 2007 Dec 5. J Cell Mol Med. 2008. PMID: 18053085 Free PMC article. Review.
-
Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.Breast Cancer Res Treat. 1991 Dec;20(1):53-62. doi: 10.1007/BF01833357. Breast Cancer Res Treat. 1991. PMID: 1813069
-
Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.Br J Cancer. 1992 Feb;65(2):177-82. doi: 10.1038/bjc.1992.37. Br J Cancer. 1992. PMID: 1739613 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials